SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,357 Cr | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr |
What is the latest Total Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,357 Cr |
| Mar2025 | ₹1,117 Cr |
| Mar2024 | ₹924 Cr |
| Mar2023 | ₹820 Cr |
| Mar2022 | ₹735 Cr |
How is Total Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,357 Cr | 21.46 | |
| Mar2025 | ₹1,117 Cr | 20.94 | |
| Mar2024 | ₹924 Cr | 12.63 | |
| Mar2023 | ₹820 Cr | 11.64 | |
| Mar2022 | ₹735 Cr | - | |
Compare Total Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹7,041.3 Cr | -0.9% | -2.7% | 22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -0.9% |
-2.7% |
22.1% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses